Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $118.7700 (-0.54%) ($118.0200 - $121.9500) on Wed. Jul. 15, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.37% (three month average) | RSI | 68 | Latest Price | $118.7700(-0.54%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 1.2% a day on average for past five trading days. | Weekly Trend | LGND advances 1.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(54%) IWO(52%) XBI(50%) IWC(47%) IWM(47%) | Factors Impacting LGND price | LGND will decline at least -1.685% in a week (0% probabilities). VIXM(-22%) UUP(-16%) VXX(-15%) IYT(-4%) UNG(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.685% (StdDev 3.37%) | Hourly BBV | 0 () | Intraday Trend | -0.7% | | | |
|
5 Day Moving Average | $115.8(2.56%) | 10 Day Moving Average | $113.96(4.22%) | 20 Day Moving Average | $113.45(4.69%) | To recent high | -3.9% | To recent low | 34.4% | Market Cap | $1.909b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |